Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the layoffs. Despite the downsizing, there is movement. Here are some of the latest changes. Recognize anyone?

And here is our regular feature. Send us a photo and we will spotlight a different person each week. This time around, we note that Lycera named Kathleen Metters as ceo and president. Previously, she spent more than 20 years at Merck, most recently as senior vp of external discovery and preclinical sciences. Before that, she was senior vp and head of worldwide basic research.

Aptuit named Jan-Olav Henck as chief scientific officer;
Johnson & Johnson says Brian Perkins, vp corporate affairs, will leave shortly;
MethylGene named Joseph Walewicz as vp, business and corporate development;
Patheon says Peter Bigelow, president of North American operations, will leave;
PhRMA says Diane Biere will step down as exec vp and general counsel;
Galena Biopharma hired Hana Moran as vp, regulatory affairs and compliance;
Somaxon Pharmaceuticals named Michael Allen as sr vp sales and marketing;
Somaxon Pharmaceticals says Jeff Raser resigned as sr vp sales and marketing;
NovaBay Pharma named David Stroman as sr vp, ophthalmic drug development;
OncoMed Pharmaceuticals named Jakob Dupont as vp of clinical research;
Geron appoints John Scarlett as new CEO
Acura Pharmaceuticals hired J. Bradley Rivet as vp of marketing;
Orexo hireds Peter Edman as chief scientific officer;
Novella named Elizabeth Edwards vp of European operations;
Achaogen named Ken Hillan as ceo;
AcelRx Pharmaceuticals added Mark Edwards to its board;
Spectrum Pharmaceuticals named Brian Holzer as exec director of brand mgmt;
Actelion elected Jean-Pierre Garnier as its chairman;
PharmAthene added Brian Markinson to its board;
Pulmatrix added Michael Yeadon to its scientific advisory board;
Theracrine hired Steven Kelly as ceo and president;
Prosonix added Ken Cunningham to its board;
Jazz Pharmaceuticals hired Jeff Tobias as sr vp, R&D and chief medical officer;
AnswerLab hired Pamela Walshe as director of research;
Biogen promoted Tony Kinglsey to head global commercial operations;
Easton Pharmaceuticals hired John Mitchell as vp of sales, North America;
Elevation Pharmaceuticals named Jaisim Shah as sr vp and chief business officer;
Elevation Pharmaceuticals named Pravin Soni as sr vp and chief technical officer;
NPS Pharmaceuticals hired Eric Pauwels as sr vp and chief commercial officer;
Delcath hired Graham Miao as cfo;
Delcath named David McDonald as exec vp, businesss development;
Medivir hired Maris Hartmanis as ceo;
MediciNova added Tatsuo Izumi to its board;
BioClinica hired Andy Dzik-Jurasz as senior medical director;
United BioSource hired Javier Cid as a research scientist and epidemiologist;
United BioSource hired Ananth Kadambi as director, modeling & simulation, health economics;
McDermott & Will added Glenn Engelmann as sr counsel in its life sciences practice;
FDA named Debra Lewis as acting director of the Office of Orphan Products Development.

Ladder shot thx to Robert CB on Flickr Creative Commons